Skip to main content
. 2011 Mar 4;32(3):345–353. doi: 10.1038/aps.2010.220

Figure 7.

Figure 7

Transfection of miR-128 inhibitor inhibited Rh2-induced caspase 3 activation in U251 cells. (A) Transfection of miR-128 inhibitor inhibited the caspase 3 activation induced by treatment with 6, 12, and 25 μg/mL Rh2 for 48 h. The cells were transfected with 50 nmol/L miR-128 inhibitor or inhibitor control for 48 h, and then with Rh2 for 48 h. (B) Transfection of miR-128 inhibitor inhibited the caspase 3 activation induced by treatment with 12 μg/mL Rh2. The cells were transfected with 50 nmol/L miR-128 inhibitor or inhibitor control for 48 h, and then with Rh2 for 24, 48, and 72 h. Caspase 3 avtivity was determined using colorimetric assay. The experiment was performed three times each in triplicate. Mean±SEM. bP<0.05 compared with control or miR-128 inhibitor+Rh2.